Apr 16–19, 2026 | Beaver Run Conference Center, Breckenridge, CO, United States
Scientific Organizers:
Penny L Moore, Marit van Gils, and Kevin O. Saunders

-
Scientific Organizers: Penny L Moore, Marit van Gils, and Kevin O. Saunders
Penny L Moore
Marit van Gils
Kevin O. Saunders
***Meeting program subject to change.
Available Formats: = Livestream = In Person = On DemandThursday, April 16, 2026
Fundraising
Booking Function
Merchandise Options
Registration Options
Friday, April 17, 2026
HIV Vaccines: Learning from the Swiss X-BNAb Cohort for Prevention and Cure
Promoting Persistent bNAb Expression in NHPs through AAV-Mediated Gene Transfer
Long-acting ART in HIV Prevention and Cure
Vaccination of PLWH, using 426C Derived Immunogens
African bNAb Immunogens
Fc Effector Function in HIV Infection and Vaccination
Viral Diversity in Central Africa: Known and Unknowns
Saturday, April 18, 2026
Triggering bNAbs in Non-Human Primates
Creating an Immune Environment Favorable for HIV-1 bnAb Induction
Progress in CMV based Vaccines
Induction of HCDR3-Binding and CD4 Mimicking Antibodies in HVTN300 and HVTN309
Germline Targeting Immunogens and Precursors in African Populations
Germline Targeting Immunogens in Human Clinical Trials; C101, C107, C110
Sunday, April 19, 2026
Injectable Hydrogel Depot Technologies for Sustained Delivery of Vaccines
Adjuvants for Mucosal Immunity
Large Language Models to Identify bnAbs and Design Vaccines to Them
Combined Immunotherapy with IL-15 Agonists and Broadly-Neutralizing Antibodies
Engineering B Cells as in vivo bnAb Factories
Combining Germline Targeting Approaches Across Diverse bNAb Epitopes
Monday, April 20, 2026
Subscribe for Updates